Skin tolerability of transdermal patches

被引:15
|
作者
Wohlrab, Johannes [1 ,2 ]
Kreft, B. [1 ]
Tamke, B. [3 ]
机构
[1] Univ Halle Wittenberg, Dept Dermatol & Venereol, D-06097 Halle, Saale, Germany
[2] Univ Halle Wittenberg, Inst Appl Dermatopharm, D-06097 Halle, Saale, Germany
[3] Univ Halle Wittenberg, Dept Anaesthesiol & Intens Care, D-06097 Halle, Saale, Germany
关键词
drug delivery; intolerance; safety and tolerability; transdermal patch systems; ALOE-VERA GEL; DRUG-DELIVERY; DOUBLE-BLIND; BARBADENSIS MILLER; THERAPEUTIC SYSTEM; PHENOLIC-COMPOUNDS; PHASE-III; EFFICACY; BUPRENORPHINE; STIMULATION;
D O I
10.1517/17425247.2011.574689
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Transdermal patch systems are an effective method of administering active ingredients through the skin, with considerable advantages over other drug delivery routes, for example, maintenance of constant plasma drug levels and avoidance of first-pass metabolism. However, repeated epicutaneous application may be associated with local skin reactions. Areas covered: This review addresses current issues regarding the effective/safe use of transdermal patch systems, and provides a critical analysis of the addition of 'skin-caring' ingredients to patch systems. Effective use of transdermal systems includes choosing an appropriate body area for application, maintaining regular skin care regimens before application and not replacing a patch in the same area (rotation) within 7 days. Another strategy, developed in an attempt to improve the tolerability of transdermal systems, is the addition of assumed 'skin-caring' ingredients (e.g., Aloe Vera) to patch systems. However, at present there is neither proof nor clinical evidence of any benefit. On the contrary, plant-derived ingredients might be associated with allergenic potential. Expert opinion: Transdermal systems are generally well tolerated; physicians must adequately inform patients of the most effective ways to use these formulations for maximum therapeutic benefit, while minimising local adverse events. Skin-caring agents, including Aloe Vera, cannot be recommended until well-controlled clinical trials with standardised extracts are available.
引用
收藏
页码:939 / 948
页数:10
相关论文
共 50 条
  • [1] Skin Tolerability of Modern Transdermal Patches
    Grossberg, George T.
    Dengiz, Alan N.
    Bouchard, Remi
    Johannsen, Peter
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (03): : S68 - S69
  • [2] Skin Tolerability Associated with Rivastigmine Transdermal Patch
    Farlow, Martin
    Cummings, Jeffrey
    Olin, Jason
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A58 - A59
  • [3] A Sustainable Solution to Skin Diseases: Ecofriendly Transdermal Patches
    Yilmaz, Eylul Gulsen
    Ece, Emre
    Erdem, Ozgecan
    Es, Ismail
    Inci, Fatih
    PHARMACEUTICS, 2023, 15 (02)
  • [4] Multiple transdermal narcotic patches associated with an intermittent skin rash
    Cappel, Jonathan
    Bruce, Alison
    Gibson, Lawrence
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB70 - AB70
  • [5] Skin tolerability associated with transdermal drug delivery systems: an overview
    Iris Ale
    Jean-Marie Lachapelle
    Howard I. Maibach
    Advances in Therapy, 2009, 26 : 920 - 935
  • [6] Skin tolerability associated with transdermal drug delivery systems: an overview
    Ale, Iris
    Lachapelle, Jean-Marie
    Maibach, Howard I.
    ADVANCES IN THERAPY, 2009, 26 (10) : 920 - 935
  • [7] Permeation studies comparing cobra skin with human skin using nicotine transdermal patches
    Pongjanyakul, T
    Prakongpan, S
    Priprem, A
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (06) : 635 - 642
  • [8] Skin Surface Protein Detection by Transdermal Analysis Patches in Pediatric Psoriasis
    Schaap, Mirjam J.
    Bruins, Finola M.
    He, Xuehui
    Orro, Kadri
    Peppelman, Malou
    van Erp, Piet E. J.
    de Jong, Elke M. G. J.
    Koenen, Hans J. P. M.
    van den Bogaard, Ellen H.
    Seyger, Marieke M. B.
    SKIN PHARMACOLOGY AND PHYSIOLOGY, 2021, 34 (05) : 271 - 280
  • [9] Randomised crossover comparison of skin irritation with two transdermal oestradiol patches
    Ross, D
    Rees, M
    Godfree, V
    Cooper, A
    Hart, D
    Kingsland, C
    Whitehead, M
    BRITISH MEDICAL JOURNAL, 1997, 315 (7103): : 288 - 288
  • [10] Enhanced Skin Permeation of Estradiol by Dimethyl Sulfoxide Containing Transdermal Patches
    Otterbach, Anna
    Lamprecht, Alf
    PHARMACEUTICS, 2021, 13 (03) : 1 - 14